Cornerstone BioPharma, a specialty pharmaceutical firm, has picked 919 Marketing of Apex NC, Adair-Greene Healthcare Communications of Atlanta and a New Jersey firm to handle its public relations and marketing.

Cornerstone is developing and commercializing nine drugs for pain, anti-infective and respiratory use.
919 will develop the overall strategic marketing programs for the company.

Natrel Communications, which is based in New Jersey, will handle marketing for two drugs, one to treat allergies and the other for treatment of pressure sores.

Adair-Greene Healthcare Communications of Atlanta will help launch a forthcoming pain medication.

Cornerstone: www.cornerstonebiopharma.com

Adair-Greene: www.adairgreene.com

919 Marketing: www.919marketing.com